The Physiology of Gastric Acid Secretion

New England Journal of Medicine

Volumn 319, Issue 26, 1988, Pages 1707-1715

  Epstein, Franklin H ^a   Wolfe, M Michael ^a   Soll, Andrew H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; OCTREOTIDE; OMEPRAZOLE; PIRENZEPINE;

CYTOCHEMISTRY; CYTOLOGY; GASTROINTESTINAL DISEASE; HUMAN; HUMAN CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION;

ANIMAL; GASTRIC ACID; HUMAN; PARIETAL CELLS, GASTRIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024215628     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198812293192605     Document Type: Review

References (83)

1. Ito S. Functional gastric morphology. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 2nd ed. Vol. 1. New York: Raven Press, 1987:817–51.
2. Berglindh T. The mammalian gastric parietal cell in vitro. Annu Rev Physiol 1984; 46: 377–92.
3. Soll AH, Berglindh T. Physiology of isolated gastric glands and parietal cells: receptors and effectors regulating function. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 2nd ed. Vol. 1. New York: Raven Press, 1987:883–909.
4. Soll AH. Secretagogue stimulation of 14C-aminopyrine accumulation by isolated canine parietal cells. Am J Physiol 1980; 238: G366–G375.
5. Leth R, Elander B, Haglund U, Olbe L, Fellenius E. Histamine H2-receptor of human and rabbit parietal cells. Am J Physiol 1987; 253: G497–G501.
6. Feldman M. Inhibition of gastric acid secretion by selective and nonselective anticholinergics. Gastroenterology 1984; 86: 361–6.
7. Herawi M, Lambrecht G, Mutschler E, Moser U, Pfeiffer A. Different binding properties of muscarinic M2-receptor subtypes for agonists and antagonists in porcine gastric smooth muscle and mucosa. Gastroenterology 1988; 94: 630–7.
8. North RA, Slack BE, Surprenant A. Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol (Lond) 1985; 368: 435–52.
9. Soll AH, Amirian DA, Thomas LP, Reedy TJ, Elashoff JD. Gastrin receptors on isolated canine parietal cells. J Clin Invest 1984; 73: 1434–47.
10. Soll AH. Extracellular calcium and cholinergic stimulation of isolated canine parietal cells. J Clin Invest 1981; 68: 270–8.
11. Chew CS, Brown MR. Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa. Biochim Biophys Acta 1986; 888: 116–25.
12. Paradiso AM, Tsien RY, Machen TE. Digital image processing of intracellular pH in gastric oxyntic and chief cells. Nature 1987; 325: 447–50.
13. Soll AH. Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [l4C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells. J Clin Invest 1980; 65: 1222–9.
14. Moss J, Bums DL, Hsia JA, Hewlett EL, Guerrant RL, Vaughan M. NIH conference: cyclic nucleotides: mediators of bacterial toxin action in disease. Ann Intern Med 1984; 101: 653–66.
15. Spiegel AM, Gierschik P, Levine MA, Downs RW Jr. Clinical implications of guanine nucleotide–binding proteins as receptor–effector couplers. N Engl J Med 1985; 312: 26–33.
16. Chen MC, Amirian DA, Toomey M, Sanders MJ, Soll AH. Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase. Gastroenterology 1988; 94: 1121–9.
17. Forte JG, Forte TM, Black JA, Okamoto C, Wolosin JM. Correlation of parietal cell structure and function. J Clin Gastroenterol 1983; 5: Suppl 1: 17–27.
18. Sachs G. The gastric proton pump: the H+,K+-ATPase. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 2nd ed. Vol. 1. New York: Raven Press, 1987:865–81.
19. Soll AH, Amirian DA, Thomas LP, et al. Gastrin receptors on nonparietal cells isolated from canine fundic mucosa. Am J Physiol 1984; 247: G715–G723.
20. Soll AH, Yamada T, Park J, Thomas LP. Release of somatostatinlike immunoreactivity from canine fundic mucosal cells in primary culture. Am J Physiol 1984; 247: G558–G566.
21. Yamada T, Soll AH, Park J, Elashoff J. Autonomic regulation of somatostatin release: studies with primary cultures of canine fundic mucosal cells. Am J Physiol 1984; 247: G567–G573.
22. Soll AH, Lewin KJ, Beaven MA. Isolation of histamine-containing cells from canine fundic mucosa. Gastroenterology 1979; 77: 1283–90.
23. Hakanson R, Bottcher G, Ekblad E, et al. Histamine in endocrine cells in the stomach: a survey of several species using a panel of histamine antibodies. Histochemistry 1986; 86: 5–17.
24. Nylander O, Bergqvist E, Obrink KJ. Dual inhibitory actions of somatostatin on isolated gastric glands. Acta Physiol Scand 1985; 125: 111–9.
25. Mittelmann B, Wolff HG. Emotions and gastroduodenal function: experimental studies on patients with gastritis, duodenitis and peptic ulcer. Psychosom Med 1942; 4: 5–61.
26. Peters MN, Richardson CT. Stressful life events, acid hypersecretion, and ulcer disease. Gastroenterology 1983; 84: 114–9.
27. Feldman M, Richardson CT, Walsh JH. Sex-related differences in gastrin release and parietal cell sensitivity in healthy human beings. J Clin Invest 1983; 71: 715–20.
28. Moore JG, Wolfe M. The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1973; 9: 97–105.
29. Feldman M, Richardson CT. Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology 1986; 90: 428–33.
30. Richardson CT, Walsh JH, Cooper KA, Feldman M, Fordtran JS. Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest 1977; 60: 435–41.
31. Feldman M, Richardson CT. 'Partial' sham feeding releases gastrin in normal human subjects. Scand J Gastroenterol 1981; 16: 13–6.
32. Wolfe MM, Jain DK, Reel GM, McGuigan JE. Effects of carbachol on gastrin and somatostatin release in rat antral tissue culture. Gastroenterology 1984; 87: 86–93.
33. Saffouri B, Weir G, Bitar K, Makhlouf G. Stimulation of gastrin secretion from the perfused rat stomach by somatostatin antiserum. Life Sci 1979; 25: 1749–53.
34. Schubert ML, Makhlouf GM. Regulation of gastrin and somatostatin secretion by intramural neurons: effect of nicotinic receptor stimulation with dimethyl-phenylpiperazinium. Gastroenterology 1982; 83: 626–32.
35. Wolfe MM, Short GM, McGuigan JE. Beta-adrenergic stimulation of gastrin release mediated by gastrin-releasing peptide in rat antral mucosa. Regul Pept 1987; 17: 133–42.
36. Sugano K, Park J, Soll AH, Yamada T. Stimulation of gastrin release by bombesin and canine gastrin-releasing peptides: studies with isolated canine G cells in primary culture. J Clin Invest 1987; 79: 935–42.
37. Roland M, Berstad A, Liavag I. Effect of carbacholine and urecholine on pentagastrin-stimulated gastric secretion in healthy subjects. Scand J Gastroenterol 1975; 10: 357–62.
38. Grotzinger U, Bergegardh S, Olbe L. Effect of atropine and proximal gastric vagotomy on the acid response to fundic distension in man. Gut 1977; 18: 303–10.
39. Lichtenberger LM. Importance of food in the regulation of gastrin release and formation. Am J Physiol 1982; 243: G429–G441.
40. Feldman EJ, Grossman MI. Liver extract and its free amino acids equally stimulate gastric acid secretion. Am J Physiol 1980; 239: G493–G496.
41. Lichtenberger LM, Delansorne R, Graziani LA. Importance of amino acid uptake and decarboxylation in gastrin release from isolated G cells. Nature 1982; 295: 698–700.
42. Saffouri B, DuVal JW, Makhlouf GM. Stimulation of gastrin secretion in vitro by intraluminal chemicals: regulation by intramural cholinergic and nonchoiinergic neurons. Gastroenterology 1984; 87: 557–61.
43. Lamers CB, Walsh JH, Jansen JB, Harrison AR, Ippoliti AF, van Tongere JH. Evidence that gastrin 34 is preferentially released from the human duodenum. Gastroenterology 1982; 83: 233–9.
44. Vagne M, Mutt V. Entero-oxyntin: a stimulant of gastric acid secretion extracted from porcine intestine. Scand J Gastroenterol 1980; 15: 17–22.
45. Isenberg JI, Maxwell V. Intravenous infusion of amino acids stimulates gastric acid secretion in man. N Engl J Med 1978; 298: 27–9.
46. Blair AJ III, Richardson CT, Walsh JH, Feldman M. Variable contribution of gastrin to gastric acid secretion after a meal in humans. Gastroenterology 1987; 92: 944–9.
47. McGuigan JE. Gastrin. Vitam Horm 1974; 32: 47–88.
48. Short GM, Doyle JW, Wolfe MM. Effect of antibodies to somatostatin on acid secretion and gastrin release by the isolated perfused rat stomach. Gastroenterology 1985; 88: 984–8.
49. Park J, Chiba T, Yamada T. Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. J Biol Chem 1987; 262: 14190–6.
50. Schubert ML, Edwards NF, Makhlouf GM. Regulation of gastric somatostatin secretion in the mouse by luminal acidity: a local feedback mechanism. Gastroenterology 1988; 94: 317–22.
51. Kosaka T, Lim RKS. Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 1930; 27: 890–1.
52. Wolfe MM, Reel GM. Inhibition of gastrin release by gastric inhibitory peptide mediated by somatostatin. Am J Physiol 1986; 250: G331–G335.
53. King CE, Toskes pp. Small intestine bacterial overgrowth. Gastroenterology 1979; 76: 1035–55.
54. Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats. Gastroenterology 1987; 92: 406–13.
55. Johnson LR, Guthrie PD. Mucosal DNA synthesis: a short term index of the trophic action of gastrin. Gastroenterology 1974; 67: 453–9.
56. Solomon TE. Trophic effects of pentagastrin on gastrointestinal tract in fed and fasted rats. Gastroenterology 1986; 91: 108–16.
57. Feldman M, Richardson CT. Total 24-hour gastric acid secretion in patients with duodenal ulcer: comparison with normal subjects and effects of cimetidine and parietal cell vagotomy. Gastroenterology 1986; 90: 540–4.
58. Blair AJ III, Feldman M, Barnett C, Walsh JH, Richardson CT. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest 1987; 79: 582–7.
59. Walsh JH, Richardson CT, Fordtran JS. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–8.
60. Lam SK, Isenberg JI, Grossman MI, Lane WH, Walsh JH. Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients. J Clin Invest 1980; 65: 555–62.
61. Chayvialle JAP, Deseos F, Bernard C, Martin A, Barbe C, Partensky C. Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease. Gastroenterology 1978; 75: 13–9.
62. Harty RF, Maico DG, McGuigan JE. Antral release of gastrin and somatostatin in duodenal ulcer and control subjects. Gut 1986; 27: 652–8.
63. Wolfe MM, Jensen RT. Zollinger–Ellison syndrome: current concepts in diagnosis and management. N Engl J Med 1987; 317: 1200–9.
64. Polak JM, Stagg B, Pearse AG. Two types of Zollinger-Ellison syndrome: immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states. Gut 1972; 13: 501–12.
65. Glowniak JV, Shapiro B, Vinik AI, Glaser B, Thompson NW, Cho KJ. Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction. N Engl J Med 1982; 307: 293–7.
66. Ganguli PC, Polak JM, Pearse AG, Elder JB, Hegarty M. Antral-gastrincell hyperplasia in peptic-ulcer disease. Lancet 1974; 1: 583–6.
67. Friesen SR, Tomita T. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor. Ann Surg 1981; 194: 481–93.
68. Stave R, Brandtzaeg P. Immunohistochemical investigation of gastrin-producing cells (G cells): estimation of antral density, mucosal distribution, and total mass of G cells in resected stomachs from patients with peptic ulcer disease. Scand J Gastroenterol 1978; 13: 199–203.
69. Lewin KJ, Yang K, Ulich T, Elashoff JD, Walsh J. Primary gastrin cell hyperplasia: report of five cases and a review of the literature. Am J Surg Pathol 1984; 8: 821–32.
70. Taylor IL, Calam J, Rotter JI, et al. Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med 1981; 95: 421–5.
71. Grossman MI, Kurata JH, Rotter JI, et al. Peptide ulcer: new therapies, new diseases. Ann Intern Med 1981; 95: 609–27.
72. Feldman M, Richardson CT, Peterson WL, Walsh JH, Fordtran JS. Effect of low-dose propantheline on food-stimulated gastric acid secretion: comparison with an “optimal effective dose” and interaction with cimetidine. N Engl J Med 1977; 297: 1427–30.
73. Texter EC Jr, Reilly PA. The efficacy and selectivity of pirenzepine: review and commentary. Scand J Gastroenterol [Suppl] 1982; 72: 237–46.
74. Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase. Nature 1981; 290: 159–61.
75. Clissold SP, Campoli-Richards DM. Omeprazole: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 1986; 32: 15–47.
76. Sachs G. Pump blockers and ulcer disease. N Engl J Med 1984; 310: 785–6.
77. Lamers CBHW, Lind T, Moberg S, Jansen JBMJ, Olbe L. Omeprazole in Zollinger–Ellison syndrome: effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med 1984; 310: 758–61.
78. Lloyd-Davies KA, Rutgersson K, Sölvell L. Omeprazole in Zollinger-Ellison syndrome: four-year international study. Gastroenterology 1986; 90: 1523. abstract.
79. Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol [Suppl] 1985; 108: 53–69.
80. Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med 1985; 312: 958–61.
81. Bardhan KD, Dhande D, Hinchliffe RFC, et al. Omeprazole in the treatment of ultra refractory duodenal ulcer. Gastroenterology 1988; 94: A22. abstract.
82. Archambult AP, Pare P, Bailey RJ, et al. Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 1988; 94: 1130–4.
83. Bonfils S, Ruszniewski P, Costil V, et al. Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin. Lancet 1986; 1: 554–5.